NasdaqCM - Delayed Quote • USD
Aptose Biosciences Inc. (APTO)
At close: April 22 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 4 | 3 |
Avg. Estimate | -0.74 | -0.65 | -4.27 | -2.72 |
Low Estimate | -0.84 | -0.94 | -8.79 | -4.03 |
High Estimate | -0.58 | -0.42 | -1.67 | -1.01 |
Year Ago EPS | -2.25 | -2.27 | -7.58 | -4.27 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 3 |
Avg. Estimate | -- | -- | -- | 510k |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | 1.54M |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -1.75 | -2.01 | -2.05 | -1.59 |
EPS Actual | -2.25 | -2.27 | -1.76 | -1.44 |
Difference | -0.5 | -0.26 | 0.29 | 0.15 |
Surprise % | -28.60% | -12.90% | 14.10% | 9.40% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.74 | -0.65 | -4.27 | -2.72 |
7 Days Ago | -0.74 | -0.65 | -4.27 | -2.72 |
30 Days Ago | -0.88 | -0.72 | -5.11 | -3.07 |
60 Days Ago | -0.88 | -0.72 | -4.46 | -2.71 |
90 Days Ago | -1.6 | -1.76 | -5.46 | -2.71 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | 1 | 1 | 3 | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | APTO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 67.10% | -- | -- | 0.20% |
Next Qtr. | 71.40% | -- | -- | 9.40% |
Current Year | 43.70% | -- | -- | 4.40% |
Next Year | 36.30% | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.07% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
RNXT RenovoRx, Inc.
1.2300
+5.13%
BLPH Bellerophon Therapeutics, Inc.
0.0511
-6.07%
AZTR Azitra, Inc.
0.1950
0.00%
ONCT Oncternal Therapeutics, Inc.
8.55
-6.56%
INAB IN8bio, Inc.
0.9999
-2.92%
ALGS Aligos Therapeutics, Inc.
0.8010
+6.80%
ALZN Alzamend Neuro, Inc.
0.6850
+1.41%
CUE Cue Biopharma, Inc.
1.5700
+0.64%
DMAC DiaMedica Therapeutics Inc.
2.5100
+5.02%
SCPS Scopus BioPharma Inc.
0.0016
0.00%